Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2016 Jun 24. pii: S0167-8140(16)31117-3. doi: 10.1016/j.radonc.2016.05.014 |
Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. |
Tanderup K1, Fokdal LU2, Sturdza A3, Haie-Meder C4, Mazeron R5, van Limbergen E6, Jürgenliemk-Schulz I7, Petric P8, Hoskin P9, Dörr W10, Bentzen SM11, Kirisits C12, Lindegaard JC13, Pötter R14 |
Abstract BACKGROUND AND PURPOSE: Currently, there is no consensus on dose prescription in image guided adaptive brachytherapy (IGABT) in locally advanced cervical cancer. The purpose of this study was to provide evidence based recommendations for tumor dose prescription based on results from a multi-center patient series (retroEMBRACE). MATERIALS AND METHODS: This study analyzed 488 locally advanced cervical cancer patients treated with external beam radiotherapy±chemotherapy combined with IGABT. Brachytherapy contouring and reporting was according to ICRU/GEC-ESTRO recommendations. The Cox Proportional Hazards model was applied to analyze the effect on local control of dose-volume metrics as well as overall treatment time (OTT), dose rate, chemotherapy, and tumor histology. RESULTS: With a median follow up of 46months, 43 local failures were observed. Dose (D90) to the High Risk Clinical Target Volume (CTVHR) (p=0.022, HR=0.967 per Gy) was significant for local control, whereas increasing CTVHR volume (p=0.004, HR=1.017 per cm(3)), and longer OTT (p=0.004, HR=1.023 per day) were associated with worse local control. Histology (p=0.084), chemotherapy (p=0.49) and dose rate (p=1.00) did not have significant impact on local control. Separate analyses according to stage of disease showed that dose to CTVHR, residual gross tumor volume (GTVres), and Intermediate Risk CTV (CTVIR) has significant impact on local control. CONCLUSION: CTVHR dose of ⩾85Gy (D90) delivered in 7weeks provides 3-year local control rates of >94% in limited size CTVHR (20cm(3)), >93% in intermediate size (30cm(3)) and >86% in large size (70cm(3)) CTVHR. CTVIR and GTVres dose of ⩾60Gy and ⩾95Gy (D98) leads to similar local control. A dose of 5Gy (CTVHR) is required to compensate an increase of OTT by one week. Increased CTVHR volume by 10cm(3) requires additional 5Gy for equivalent local control. |
Copyright © 2016. Published by Elsevier Ireland Ltd. |
KEYWORDS: Cervical cancer, Dose effect, Image guided brachytherapy, Local control, Overall treatment time |
Publikations ID: 27350396 Quelle: öffnen |